Login to Your Account

'Yumanity' possible: $45M series A to propel pipeline to the clinic

By Marie Powers
News Editor

Wednesday, February 10, 2016

Yumanity Therapeutics pulled down a $45 million series A led by Fidelity Management & Research Co. – "the investment group, not the venture group," Tony Coles, chairman and CEO, clarified – in a vote of institutional confidence that "almost never happens" in an early round, he said.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription